These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28192156)

  • 21. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.
    Larson AM; Fung AM; Fang FC
    J Clin Microbiol; 2010 Jan; 48(1):124-30. PubMed ID: 19923482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of enzyme immunoassays and rapid diagnostic tests for clostridium difficile glutamate dehydrogenase and toxin a + B to toxinogenic culture on a highly selective chromogenic medium.
    Olling A; Leidinger H; Hoffmann R
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1655-9. PubMed ID: 27323765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B.
    Savolainen R; Koskinen JM; Mentula S; Koskinen JO; Kaukoranta SS
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31941691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
    Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
    Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro Cd polymerase chain reaction as confirmatory procedures.
    Doing KM; Hintz MS; Keefe C; Horne S; LeVasseur S; Kulikowski ML
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):129-34. PubMed ID: 20117349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous Detection of
    Yoo IY; Song DJ; Huh HJ; Lee NY
    Ann Lab Med; 2019 Mar; 39(2):214-217. PubMed ID: 30430786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of toxigenic Clostridioides [Clostridium] difficile: Usefulness of two commercially available enzyme immunoassays and a PCR assay on stool samples and stool isolates.
    Legaria MC; Rollet R; Di Martino A; Castello L; Barberis C; Rossetti MA; Guardati MC; Fernández Canigia L; Carloni G; Litterio M; Rocchi M; Anchart EG; Trejo FM; Minnaard J; Klajn D; Predari SC
    Rev Argent Microbiol; 2018; 50(1):36-44. PubMed ID: 28988901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.
    Bogaty C; Lévesque S; Garenc C; Frenette C; Bolduc D; Galarneau LA; Lalancette C; Loo V; Tremblay C; Trudeau M; Vachon J; Dionne M; Villeneuve J; Longtin J; Longtin Y;
    Am J Infect Control; 2017 Sep; 45(9):964-968. PubMed ID: 28549882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effect of strain type on detection of toxigenic Clostridium difficile by glutamate dehydrogenase and polymerase chain reaction.
    Goldenberg SD; Gumban M; Hall A; Patel A; French GL
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):417-9. PubMed ID: 21683272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Clostridium difficile toxin A and B genes from stool samples of Thai diarrheal patients by polymerase chain reaction technique.
    Wongwanich S; Rugdeekha S; Pongpech P; Dhiraputra C
    J Med Assoc Thai; 2003 Oct; 86(10):970-5. PubMed ID: 14650710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Clostridium difficile infection: a suggested laboratory diagnostic algorithm.
    Wren MW; Kinson R; Sivapalan M; Shemko M; Shetty NR
    Br J Biomed Sci; 2009; 66(4):175-9. PubMed ID: 20095124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.
    Snell H; Ramos M; Longo S; John M; Hussain Z
    J Clin Microbiol; 2004 Oct; 42(10):4863-5. PubMed ID: 15472364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples.
    Stahlmann J; Schönberg M; Herrmann M; von Müller L
    Clin Microbiol Infect; 2014 Sep; 20(9):O590-2. PubMed ID: 24450741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance evaluation of the Verigene
    Kosai K; Iwanaga Y; Akamatsu N; Okada Y; Kaku N; Uno N; Morinaga Y; Hasegawa H; Miyazaki T; Izumikawa K; Mukae H; Yanagihara K
    J Infect Chemother; 2017 Oct; 23(10):674-677. PubMed ID: 28751156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory diagnosis of clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory.
    Wren MW; Sivapalan M; Kinson R; Shetty NR
    Br J Biomed Sci; 2009; 66(1):1-5. PubMed ID: 19348118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of 4 molecular assays as part of a 2-step algorithm for the detection of Clostridium difficile in stool specimens.
    Caulfield AJ; Bolster LaSalle CM; Chang YH; Grys TE
    Diagn Microbiol Infect Dis; 2018 May; 91(1):1-5. PubMed ID: 29428547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Diagnostic Algorithms for Detecting Toxigenic Clostridium difficile in Routine Practice at a Tertiary Referral Hospital in Korea.
    Moon HW; Kim HN; Hur M; Shim HS; Kim H; Yun YM
    PLoS One; 2016; 11(8):e0161139. PubMed ID: 27532104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New methodological advances: algorithm proposal for management of Clostridium difficile infection].
    González-Abad MJ; Alonso-Sanz M
    Rev Esp Quimioter; 2015 Jun; 28(3):157-9. PubMed ID: 26033001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential value of repeat stool testing for Clostridium difficile stool toxin using enzyme immunoassay?
    Deshpande A; Pasupuleti V; Pant C; Hall G; Jain A
    Curr Med Res Opin; 2010 Nov; 26(11):2635-41. PubMed ID: 20923255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular test to determine toxigenic capabilities in GDH-positive, toxin-negative samples: evaluation of the Portrait toxigenic C. difficile assay.
    Finch LS; Duncan CM
    Br J Biomed Sci; 2013; 70(2):62-6. PubMed ID: 23888607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.